Sugammadex Titration in Cardiac Surgery Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT05246397

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05246397
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05246397. Allocation not applicable; no masking; primary purpose other. Start 2022-02-01 (actual); primary completion 2022-11-10 (actual). Results posted on 2024-03-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sugammadex Titration in Cardiac Surgery Patients
Condition
Valvular Heart Disease
Condition
Aorta Disease
Condition
Heart Failure
Intervention (Drug)
Sugammadex administration
Lead sponsor
University of Washington (class: other)

Record details

Record id
cardio:ct-nct05246397
Content hash
fd530de2a80c7f2911a79b15089e5ab12f2164b955092e4a3da10f9f95e5e473